Nicolas Béry

1.4k total citations
28 papers, 932 citations indexed

About

Nicolas Béry is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Nicolas Béry has authored 28 papers receiving a total of 932 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 14 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Oncology. Recurrent topics in Nicolas Béry's work include Monoclonal and Polyclonal Antibodies Research (14 papers), Protein Kinase Regulation and GTPase Signaling (7 papers) and Protein Degradation and Inhibitors (5 papers). Nicolas Béry is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (14 papers), Protein Kinase Regulation and GTPase Signaling (7 papers) and Protein Degradation and Inhibitors (5 papers). Nicolas Béry collaborates with scholars based in France, United Kingdom and Italy. Nicolas Béry's co-authors include Terence H. Rabbitts, Ami Miller, Aurélien Olichon, Gilles Favre, Laura Keller, Lætitia Ligat, Ario de Marco, Angela J. Russell, Carole J. R. Bataille and Abimael Cruz-Migoni and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Analytical Chemistry.

In The Last Decade

Nicolas Béry

27 papers receiving 921 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolas Béry France 13 762 350 212 91 84 28 932
David Coomber Singapore 15 536 0.7× 201 0.6× 296 1.4× 69 0.8× 107 1.3× 21 728
Peter A. Hoyne Australia 8 677 0.9× 550 1.6× 606 2.9× 52 0.6× 84 1.0× 10 1.1k
Gabriela Nagy‐Davidescu Switzerland 9 371 0.5× 329 0.9× 207 1.0× 27 0.3× 60 0.7× 10 571
Rastislav Tamaskovic Switzerland 12 913 1.2× 311 0.9× 331 1.6× 405 4.5× 82 1.0× 13 1.3k
Cynthia Seidel‐Dugan United States 16 977 1.3× 202 0.6× 244 1.2× 221 2.4× 252 3.0× 24 1.4k
Olivier Zwaenepoel Belgium 15 410 0.5× 250 0.7× 115 0.5× 104 1.1× 118 1.4× 28 620
Tatiana A. Slastnikova Russia 16 402 0.5× 226 0.6× 103 0.5× 39 0.4× 51 0.6× 30 629
Caroline Ekblad Sweden 12 329 0.4× 308 0.9× 178 0.8× 23 0.3× 87 1.0× 13 563
Karl Proba Switzerland 8 537 0.7× 328 0.9× 60 0.3× 96 1.1× 90 1.1× 9 701
Richard G. Hibbert Netherlands 18 878 1.2× 156 0.4× 250 1.2× 129 1.4× 212 2.5× 20 1.1k

Countries citing papers authored by Nicolas Béry

Since Specialization
Citations

This map shows the geographic impact of Nicolas Béry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Béry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Béry more than expected).

Fields of papers citing papers by Nicolas Béry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Béry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Béry. The network helps show where Nicolas Béry may publish in the future.

Co-authorship network of co-authors of Nicolas Béry

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Béry. A scholar is included among the top collaborators of Nicolas Béry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Béry. Nicolas Béry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Béry, Nicolas, Marion Gayral, Lucille Stuani, et al.. (2024). Cytidine deaminase-dependent mitochondrial biogenesis as a potential vulnerability in pancreatic cancer cells. Communications Biology. 7(1). 1065–1065. 6 indexed citations
2.
Vigne, Emmanuelle, et al.. (2024). Discovery of SOCS7 as a versatile E3 ligase for protein-based degraders. iScience. 27(5). 109802–109802. 4 indexed citations
3.
Cristini, Agnese, Nicolas Béry, Marco Russo, et al.. (2024). TDP1 mutation causing SCAN1 neurodegenerative syndrome hampers the repair of transcriptional DNA double-strand breaks. Cell Reports. 43(5). 114214–114214. 9 indexed citations
4.
Ligat, Lætitia, et al.. (2023). Defeating gemcitabine resistance in pancreatic tumours with antibody-based CDA degrader. Pancreatology. 23. e12–e12. 1 indexed citations
5.
Keller, Laura, Claudine Tardy, Lætitia Ligat, et al.. (2022). Tripartite split-GFP assay to identify selective intracellular nanobody that suppresses GTPase RHOA subfamily downstream signaling. Frontiers in Immunology. 13. 980539–980539. 1 indexed citations
6.
Cristini, Agnese, Michael Tellier, Laura-Oana Albulescu, et al.. (2022). RNase H2, mutated in Aicardi‐Goutières syndrome, resolves co-transcriptional R-loops to prevent DNA breaks and inflammation. Nature Communications. 13(1). 2961–2961. 54 indexed citations
7.
Béry, Nicolas & Terence H. Rabbitts. (2022). A Cell-based Screening Method Using an Intracellular Antibody for Discovering Small Molecules Targeting Hard-to-drug Proteins. BIO-PROTOCOL. 12(4). e4324–e4324. 1 indexed citations
8.
Béry, Nicolas, Carole J. R. Bataille, Angela J. Russell, et al.. (2021). A cell-based screening method using an intracellular antibody for discovering small molecules targeting the translocation protein LMO2. Science Advances. 7(15). 11 indexed citations
9.
Canning, Peter, Carole J. R. Bataille, Nicolas Béry, et al.. (2021). Competitive SPR using an intracellular anti-LMO2 antibody identifies novel LMO2-interacting compounds. Journal of Immunological Methods. 494. 113051–113051. 5 indexed citations
10.
11.
Béry, Nicolas, Ami Miller, & Terence H. Rabbitts. (2020). A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS. Nature Communications. 11(1). 3233–3233. 81 indexed citations
12.
Béry, Nicolas, Gilles Favre, & Aurélien Olichon. (2020). Protocol to select conformation-specific intracellular antibodies for targeted protein degradation in an engineered cell line. STAR Protocols. 2(1). 100249–100249. 1 indexed citations
13.
Cruz-Migoni, Abimael, Peter Canning, Camilo Quevedo, et al.. (2019). Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds. Proceedings of the National Academy of Sciences. 116(7). 2545–2550. 101 indexed citations
14.
Pais, Helio, Katia Ruggero, Jing Zhang, et al.. (2019). Surfaceome interrogation using an RNA-seq approach highlights leukemia initiating cell biomarkers in an LMO2 T cell transgenic model. Scientific Reports. 9(1). 5760–5760. 10 indexed citations
15.
Béry, Nicolas, Laura Keller, Stéphanie Cabantous, et al.. (2019). A Targeted Protein Degradation Cell-Based Screening for Nanobodies Selective toward the Cellular RHOB GTP-Bound Conformation. Cell chemical biology. 26(11). 1544–1558.e6. 32 indexed citations
16.
Quevedo, Camilo, Abimael Cruz-Migoni, Nicolas Béry, et al.. (2018). Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment. Nature Communications. 9(1). 3169–3169. 98 indexed citations
17.
Guillard, Sandrine, Paulina Kolasinska-Zwierz, J.E. Debreczeni, et al.. (2017). Structural and functional characterization of a DARPin which inhibits Ras nucleotide exchange. Nature Communications. 8(1). 16111–16111. 74 indexed citations
18.
Moutel, Sandrine, Nicolas Béry, Virginie Bernard, et al.. (2016). NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies. eLife. 5. 226 indexed citations
19.
Jullien, Denis, Julien Vignard, Nicolas Béry, et al.. (2016). Chromatibody, a novel non-invasive molecular tool to explore and manipulate chromatin in living cells. Journal of Cell Science. 129(13). 2673–2683. 33 indexed citations
20.
Monegal, Ana, Aurélien Olichon, Nicolas Béry, et al.. (2011). Single domain antibodies with VH hallmarks are positively selected during panning of llama (Lama glama) naïve libraries. Developmental & Comparative Immunology. 36(1). 150–156. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Coomber Breakdown of academic impact, for papers by Peter A. Hoyne Breakdown of academic impact, for papers by Gabriela Nagy‐Davidescu Breakdown of academic impact, for papers by Rastislav Tamaskovic Breakdown of academic impact, for papers by Cynthia Seidel‐Dugan Breakdown of academic impact, for papers by Olivier Zwaenepoel Breakdown of academic impact, for papers by Tatiana A. Slastnikova Breakdown of academic impact, for papers by Caroline Ekblad Breakdown of academic impact, for papers by Karl Proba Breakdown of academic impact, for papers by Richard G. Hibbert
Rankless by CCL
2026